Real-World Survival in Patients with Metastatic Melanoma after Discontinuation of Anti-PD-1 Immunotherapy for Objective Response or Adverse Effects: A Retrospective StudyJulie Valentin, E. Gérard, Thomas Ferté et al.|Journal of Oncology|2021Cited by 21